Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 3 recruiting now small index

Mitral Valve Disease clinical trials

3 of 6 indexed Mitral Valve Disease trials are currently recruiting.

Corpus placement: #2,866 of 28,707 conditions by registered trial count.

6 US clinical trials · 3 currently recruiting · #2,866 of 28,707 conditions by registered trial count

Mitral Valve Disease: 6 US clinical trials tracked, 3 recruiting.

Mitral Valve Disease is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. The most active sponsor is Abbott Medical Devices, running 2 of these trials.

Enrollment posture brief

Registry condition mitral-valve-disease

OPEN 3 | RECR 50% | LATE 0 | EARLY 0 | RANK #2866 | SPON 2

Nearest open-share peer: Achalasia (50% recruiting · 8 trials)

Acute Hypoxemic Respiratory 66.7%Abdominal Aortic Aneurysms50%Acupuncture50%Acute Lymphoblastic Leukemia50%Mitral Valve Disease (this)50%
Open-enrollment share among volume-matched conditions near Mitral Valve Disease

Mitral Valve Disease lists 3 open slots (50% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Mitral Valve Disease on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Mitral Valve Disease is recruiting above its size-band peers.

    3 of 6 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Mitral Valve Disease research.

    Abbott Medical Devices accounts for 2 of 6 trials (33.3%). 5 distinct sponsors appear on at least one study for this condition label.

  3. Typical Mitral Valve Disease enrolment sits around 210 participants.

    Median target enrolment is 210 among the 6 trials that report a genuine target (sentinel values excluded). 3 of those (50%) plan for fewer than 100 participants.

  4. Mitral Valve Disease splits between interventional and observational designs.

    4 interventional and 2 observational studies make up this index (66.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase Distribution

Phase data not available

Named interventions

Most-linked intervention names on Mitral Valve Disease records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Edwards SAPIEN 3 transcatheter valve, Model 9600TFX Device
1 trials
Tendyne Mitral Valve System Device
1 trials
Millipede Transcatheter Annuloplasty Ring System (Millipede System) Device
1 trials
Transseptal ViMAC Device
1 trials

US sites by state

Facility locations filed on Mitral Valve Disease trials. A trial with sites in several states counts in each.

New York 5 trials
Minnesota 4 trials
Arizona 4 trials
Texas 3 trials
Oregon 3 trials
Massachusetts 3 trials
Kansas 3 trials
Illinois 3 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Mitral Valve Disease page

6 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Mitral Valve Disease condition card totals 6 registered trials; most-linked intervention Edwards SAPIEN 3 transcatheter valve, Model 9600TFX; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.